Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 9/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.37 |
| ▸ | NAMPT | P43490 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10072933 | 0.90 | USP2 (0.49) | USP2SMN1; SMN2LMNAMAPK1RAB9A | |
| SCHEMBL29053849 | 0.83 | USP2 (0.41) | GPR119USP2SMN1; SMN2LMNAHPGD | |
| SCHEMBL484800 | 0.83 | GPR119 (0.45) | GPR119USP2SMN1; SMN2HPGDNAMPT | |
| SCHEMBL346995 | 0.81 | USP2 (0.56) | GPR119USP2SMN1; SMN2HPGDCYP2D6 | |
| SCHEMBL27282761 | 0.80 | CYP1A2 (0.44) | USP2SMN1; SMN2LMNAMAPK1RAB9A | |
| SCHEMBL15475694 | 0.80 | USP2 (0.43) | USP2SMN1; SMN2LMNAHPGDEPHX2 | |
| SCHEMBL30751711 | 0.80 | GPR119 (0.39) | GPR119LMNAMAPK1RAB9ANAMPT | |
| SCHEMBL30736650 | 0.79 | CYP1A2 (0.43) | LMNAMAPK1RAB9ACYP2D6 | |
| SCHEMBL15476186 | 0.79 | USP2 (0.42) | USP2SMN1; SMN2LMNAHPGDEPHX2 | |
| SCHEMBL18497401 | 0.79 | NR1H2 (0.41) | USP2SMN1; SMN2LMNAMAPK1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4561575-A2 | CDK2 INHIBITORS AND METHODS OF USING THE SAME | Cedilla Therapeutics, Inc. (US) | 2025-06-04 | — | — | EP | disclosed |